Advanced Search
ZHOU Silei, SUN Guanqun, ZENG Tanlun, CHENG Zhuo, LIANG Xijun. Expression and Prognostic Value of CK2α' in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2022, 49(7): 662-666. DOI: 10.3971/j.issn.1000-8578.2022.21.1291
Citation: ZHOU Silei, SUN Guanqun, ZENG Tanlun, CHENG Zhuo, LIANG Xijun. Expression and Prognostic Value of CK2α' in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2022, 49(7): 662-666. DOI: 10.3971/j.issn.1000-8578.2022.21.1291

Expression and Prognostic Value of CK2α' in Hepatocellular Carcinoma

Funding: 

National Natural Science Foundation of China 81801570

More Information
  • Corresponding author:

    LIANG Xijun, E-mail: liangxj_0711@163.com

  • (*: Contributed Equally as the First Author )

  • Received Date: November 08, 2021
  • Revised Date: April 06, 2022
  • Available Online: January 12, 2024
  • Objective 

    To investigate the expression of CK2α' in hepatocellular carcinoma (HCC) tissues and its prognosis value.

    Methods 

    Tissue microarray was made from tumor and adjacent normal tissues of 83 patients with HCC. Immunohistochemical was used to stain the microarray for semi-quantitative analysis, and the expression of CK2α' in HCC tissues and adjacent normal tissues was compared. The associations between CK2α' expression and clinicopathologic features of HCC patients were analyzed with χ2 text. The prognostic value of CK2α' was estimated using Kaplan-Meier approach.

    Results 

    The average positive expression rate of CK2α' was 47.8% in HCC and 65.4% in adjacent normal tissues. The positive expression rate of CK2α' in HCC tissues was lower than that in adjacent normal tissues (P < 0.01). The expression level of CK2α' in the cancer tissues of 74.7% cases was significantly lower than that in the adjacent tissues. HCC patients with low CK2α' expression had higher risk of recurrence and shorter overall survival time (P < 0.05). The expression of CK2α' was significantly correlated with CK19 (P < 0.05).

    Conclusion 

    CK2α' is down-regulated in HCC tissues and correlated with the prognosis of patients. It could be a potential prognostic marker for HCC.

  • Competing interests: The authors declare that they have no competing interests.

  • [1]
    Liu Y, Veeraraghavan V, Pinkerton M, et al. Viral Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Occurrence and Recurrence[J]. Front Microbiol, 2021, 12: 665201. doi: 10.3389/fmicb.2021.665201
    [2]
    Zhang Z, Chen P, Xie H, et al. Overexpression of GINS4 Is Associated With Tumor Progression and Poor Survival in Hepatocellular Carcinoma[J]. Front Oncol, 2021, 11: 654185. doi: 10.3389/fonc.2021.654185
    [3]
    Borgo C, D'Amore C, Sarno S, et al. Protein kinase CK2: a potential therapeutic target for diverse human diseases[J]. Signal Transduct Target Ther, 2021, 6(1): 183.
    [4]
    Chua M, Lee M, Dominguez IM. Cancer-type dependent expression of CK2 transcripts[J]. PLos One, 2017, 12(12): e0188854. doi: 10.1371/journal.pone.0188854
    [5]
    Roffey SE, Litchfield DW. CK2 Regulation: Perspectives in 2021[J]. Biomedicines, 2021, 9(10): 1361. doi: 10.3390/biomedicines9101361
    [6]
    Seongrak K, Sunyoung H, Kyungmi Y, et al. Protein kinase CK2 activation is required for transforming growth factor-β-induced epithelial-mesenchymal transition[J]. Mol Oncol, 2018, 12(10): 1811-1826. doi: 10.1002/1878-0261.12378
    [7]
    de Villavicencio-Diaz TN, Rabalski AJ, Litchfield DW. Protein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks[J]. Pharmaceuticals (Basel)2017, 10(1): 27.
    [8]
    Pinna LA. Protein kinase CK2: a challenge to canons[J]. J Cell Sci, 2002, 115(Pt 20): 3873-3878.
    [9]
    Borgo C, Ruzzene M. Role of protein kinase CK2 in antitumor drug resistance[J]. J Exp Clin Cancer Res, 2019, 38(1): 287. doi: 10.1186/s13046-019-1292-y
    [10]
    Dominguez I, Mizuno J, Wu H, et al. A role for CK2alpha/beta in Xenopus early embryonic development[J]. Mol Cell Biochem, 2005, 274(1-2): 125-131. doi: 10.1007/s11010-005-3073-5
    [11]
    Dominguez I, Mizuno J, Wu H, et al. Protein kinase CK2 is required for dorsal axis formation in Xenopus embryos[J]. Dev Biol, 2004, 274(1): 110-124. doi: 10.1016/j.ydbio.2004.06.021
    [12]
    Hong H, Benveniste EN. The Immune Regulatory Role of Protein Kinase CK2 and Its Implications for Treatment of Cancer[J]. Biomedicines, 2021, 9(12): 1932. doi: 10.3390/biomedicines9121932
    [13]
    Channavajhala P, Seldin DC. Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis[J]. Oncogene, 2002, 21(34): 5280-5288.
    [14]
    Gomes AM, Soares MV, Ribeiro P, et al. Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels[J]. Haematologica, 2014, 99(6): 1062-1068.
    [15]
    Storz MN, van de Rijn M, Kim YH, et al. Gene expression profiles of cutaneous B cell lymphoma[J]. J Invest Dermatol, 2003, 120(5): 865-870.
    [16]
    Lian H, Su M, Zhu Y, et al. Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma Management[J]. Asian Pac J Cancer Prev, 2019, 20(1): 23-32.
    [17]
    安晓刚, 马万龙, 马玉, 等. 血清细胞角蛋白19检测在原发性肝癌中的应用价值[J]. 宁夏医科大学学报, 2018, 40(2): 211-213. https://www.cnki.com.cn/Article/CJFDTOTAL-XNXY201802024.htm

    An XG, Ma WL, Ma Y, et al. Application value of serum cytokeratin 19 in primary liver cancer[J]. Ningxia Yi Ke Da Xue Xue Bao, 2018, 40(2): 211-213. https://www.cnki.com.cn/Article/CJFDTOTAL-XNXY201802024.htm
    [18]
    Chen Y, Chen J, Zhang Y, et al. Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging[J]. J Hepatocell Carcinoma, 2021, 8: 795-808.
    [19]
    Piñero F, Dirchwolf M, Pessôa MG. Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment[J]. Cells, 2020, 9(6): 1370.
  • Related Articles

    [1]TIAN Tian, TANG Sudan. Association Between Platelet Lymphocyte Ratio and Prognosis of Non-small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Inhibitor: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2021, 48(6): 611-616. DOI: 10.3971/j.issn.1000-8578.2021.20.1052
    [2]WEI Xueling, LAN Mei, PENG Xinhao, ZHANG Hanyi, LONG En, LIU Hui, LANG Jinyi. Correlation Between Immune Function Status and EBV DNA in Patients with Nasopharyngeal Carcinoma and Their Influence on Prognosis[J]. Cancer Research on Prevention and Treatment, 2021, 48(6): 600-606. DOI: 10.3971/j.issn.1000-8578.2021.20.1402
    [3]Yeerhanati·Hudusi, Aerhengbieke·Tuhanbai, Aikebaier·Younusi. Relation Between NLR, LMR, PLR and Prognosis of Osteosarcoma[J]. Cancer Research on Prevention and Treatment, 2021, 48(4): 381-386. DOI: 10.3971/j.issn.1000-8578.2021.20.0895
    [4]XU Liang, ZHANG Baihong. Prognostic Value of Lymphocyte-associated Inflammatory Markers in Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2020, 47(12): 936-941. DOI: 10.3971/j.issn.1000-8578.2020.20.1179
    [5]YAO Zhiqiang, ZHANG Xiangxiang, CHEN Chaohu, CAO Jinlong, HAN Dali, LI Pan, DONG Zhichun, TIAN Junqiang. Prognostive Value of Preoperative Fibrinogen Combined with Platelet-lymphocyte Ratio on Prognosis of Patients Undergoing Radical Cystectomy[J]. Cancer Research on Prevention and Treatment, 2020, 47(11): 834-838. DOI: 10.3971/j.issn.1000-8578.2020.19.1631
    [6]FU Yali, MEI Shiwen, WEI Xing, LUO Chenghua, LIN Li, LIANG Jun. Neutrophil to Lymphocyte Ratio in Retroperitoneal Liposarcoma and Other Prognostic Factors[J]. Cancer Research on Prevention and Treatment, 2019, 46(2): 127-130. DOI: 10.3971/j.issn.1000-8578.2019.18.1096
    [7]TANG Hong, WU Weili, JIN Feng, LONG Jinhua, LI Yuanyuan, LUO Xiuling, GONG Xiuyun, CHEN Xiaoxiao, ZHANG Mang, YANG Chunli. Relationship of Peripheral Blood Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio with Curative Effect and Prognosis of Patients with Locally Advanced Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2019, 46(1): 32-36. DOI: 10.3971/j.issn.1000-8578.2019.18.0578
    [8]ZHANG Tingting, WANG Xiangyi, GUO Ziwei, DING Xiaosheng, LIANG Jun. Prognostic Significance of Platelet-lymphocyte Ratio in Hepatocellular Carcinoma Patients: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2018, 45(10): 775-780. DOI: 10.3971/j.issn.1000-8578.2018.18.0151
    [9]HU Gen, LI Wei, SHAO Guoyi, ZHANG Xian. Predictive Effect of Preoperative Platelet-lymphocyte Ratio on Prognosis of Patients with Gastric Stromal Tumor[J]. Cancer Research on Prevention and Treatment, 2018, 45(7): 479-482. DOI: 10.3971/j.issn.1000-8578.2018.17.1428
    [10]ZHANG Sisi, YUAN Lei. Preoperative Platelet-to-lymphocyte Ratio and Neutrophil-to-lymphocyte Ratio for Predicting Prognosis of Esophageal Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2017, 44(12): 811-815. DOI: 10.3971/j.issn.1000-8578.2017.17.0547

Catalog

    Figures(2)  /  Tables(1)

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return